Sibanda, Omphemetse2017-08-212017-08-212009Sibanda, O. (2009). Parallel importation and compulsory licensing in Kenya and South Africa as measures to access HIV/AIDS medicine. Acta Academica, 41(1), 183-206.2415-0479 (online)0587-2405 (print)http://hdl.handle.net/11660/6610English: This article briefly examines the legal framework and the use of parallel importation and compulsory licensing in South Africa and Kenya, and the extent to which the two countries utilise these measures to enhance access to HIV/AIDS medicine. The study reveals that both countries have adopted appropriate TRIPs-compliant parallel importation and compulsory licensing legislation. However, this legislation is yet to be used significantly to address the HIV/AIDS pandemic. Some of the perceived restrictions and complexities of the conditionalities of TRIPs flexibilities are notable disincentives. Although South Africa and Kenya have some pharmaceutical manufacturing capacity, this is found to have some critical limitations.Afrikaans: Hierdie artikel ondersoek kortliks die regsraamwerk en die gebruik van paralleleinvoer en verpligte lisensiëring in Suid-Afrika en Kenia, en die mate waarin die twee lande hierdie maatreëls gebruik om toegang tot HIV/VIGS-medikasie te verbeter. Die studie stel bekend dat albei lande gepaste parallele invoer- en verpligte lisensiëringswetgewing aanvaar het wat aan TRIPS-vereistes voldoen. Hierdie wetgewing is egter nog nie betekenisvol gebruik om die HIV/VIGS-pandemie te hanteer nie. Sommige van die waargenome beperkings en probleme van die voorwaardelikheid van TRIPS-buigsaamheid is aansienlike hindernisse. Alhoewel Suid-Afrika en Kenia ’n mate van farmaseutiese vervaardigingskapasiteit het, is bevind dat dit sekere kritieke beperkings het.enHIV/AIDS medicinePharmaceutical manufacturing capacityAccess to HIV/AIDS medicineSouth Africa, MedicineKenya, MedicineArticleUniversity of the Free State